Publication | Open Access
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
13
Citations
39
References
2022
Year
Gastrointestinal OncologyMedicinePathologyColorectal CancerUpfront FolfoxiriCancer TreatmentOncologyRadiation OncologyLocation Matter
| Year | Citations | |
|---|---|---|
Page 1
Page 1